Survival analysis of distant metastasis of laryngeal carcinoma: analysis based on SEER database
- PMID: 30542764
- DOI: 10.1007/s00405-018-5244-5
Survival analysis of distant metastasis of laryngeal carcinoma: analysis based on SEER database
Abstract
Background: The purpose of this study was to investigate the prognostic factors and the value of surgical treatment of patients with newly diagnosed laryngeal cancer with distant metastasis (DM).
Methods: The Surveillance, Epidemiology and End Result database (SEER) was used to analyze 446 patients with laryngeal cancer with DM at the time of initial diagnosis from 2010 to 2014.The survival prognosis of patients with DM was performed by using Kaplan-Meier and log-rank test. The prognostic factors and the effect of surgery were analyzed using the Cox regression analysis and R-language data package.
Results: The incidence of DM was 3.21% (446/13865). Lung was the most common distant metastatic site of laryngeal cancer (62.6%), and brain metastases had the worst prognosis in patients at 2 months. T stage and brain metastasis were independent risk factors affecting the survival (P < 0.05). The hazard ratio (HR) of DM in T4 stage was nearly twice than that in T1 stage. Surgical treatment of primary and metastatic tumors can cause better survival for patients. Patients who didn't underwent primary tumor surgery were approximately twice as likely to die from cancer as those who did. The nomogram model was constructed to visually present the 1-, 2- and 3-year survival rates of patients.
Conclusions: T stage, brain metastasis and surgical treatment are prognostic factors of patients with M1 stage laryngeal cancer. Surgical treatment of primary tumors and metastases can lead to better survival for patients.
Trial registration: Not applicable.
Keywords: Distant metastasis; Laryngeal cancer; Prognosis; SEER; Surgical treatment.
Similar articles
-
Distant metastases in laryngeal squamous cell carcinoma.J Exp Clin Cancer Res. 1999 Sep;18(3):285-8. J Exp Clin Cancer Res. 1999. PMID: 10606170
-
Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.Head Neck. 2016 Sep;38(9):1380-6. doi: 10.1002/hed.24443. Epub 2016 Mar 25. Head Neck. 2016. PMID: 27014858
-
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028. Laryngoscope. 2001. PMID: 11404625
-
Cancer of the Larynx-20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and ICD-O-3 Topographic Primary Sites-Codes C32.0-9: A Systematic Review of 43,103 Cases for Diagnosis Years 1975-2017: (NCI SEER*Stat 8.3.9).J Insur Med. 2024 Jul 1;51(2):92-110. doi: 10.17849/insm-51-2-92-110.1. J Insur Med. 2024. PMID: 39266004
-
Prognostic factors in laryngeal carcinoma.Clin Otolaryngol Allied Sci. 1988 Oct;13(5):399-409. doi: 10.1111/j.1365-2273.1988.tb00773.x. Clin Otolaryngol Allied Sci. 1988. PMID: 3072131 Review. No abstract available.
Cited by
-
Non-invasive screening for laryngeal cancer using the oral cavity as a proxy for differentiation of laryngeal cancer versus leukoplakia: A novel application of ESS technology and artificial intelligence supported statistical modeling.Am J Otolaryngol. 2025 Jan-Feb;46(1):104581. doi: 10.1016/j.amjoto.2024.104581. Epub 2024 Dec 24. Am J Otolaryngol. 2025. PMID: 39742670
-
A population-based model identifying optimal candidate for primary tumor resection in distant metastatic laryngeal carcinoma.Eur Arch Otorhinolaryngol. 2023 Jun;280(6):2885-2896. doi: 10.1007/s00405-023-07851-y. Epub 2023 Jan 25. Eur Arch Otorhinolaryngol. 2023. PMID: 36695908
-
Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer.Eur Arch Otorhinolaryngol. 2021 Apr;278(4):1129-1138. doi: 10.1007/s00405-020-06444-3. Epub 2020 Oct 27. Eur Arch Otorhinolaryngol. 2021. PMID: 33108563
-
Single-cell atlas profiling revealed cellular characteristics and dynamic changes after PD-1 blockade therapy of brain metastases from laryngeal squamous cell carcinoma.Mol Cell Biochem. 2025 Apr;480(4):2377-2400. doi: 10.1007/s11010-024-05064-3. Epub 2024 Aug 1. Mol Cell Biochem. 2025. PMID: 39085744 Free PMC article.
-
Role of Clinical-Demographic Data in Survival Rates of Advanced Laryngeal Cancer.Medicina (Kaunas). 2021 Mar 15;57(3):267. doi: 10.3390/medicina57030267. Medicina (Kaunas). 2021. PMID: 33804150 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources